Zolunicant (MM-110) is a potent inhibitor against nicotinic alpha3beta4 receptors with an IC50 of 0.90 µM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse[1]. Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis[2].
Molecular Weight:
368.47
Purity:
99.29
CAS Number:
[188125-42-0]
Formula:
C22H28N2O3
Target:
nAChR,Parasite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
